Monday, September 15, 2014 6:49:05 PM
eugeneseymourmd@mac.com
4:47 PM (1 hour ago)
to me
This is really getting scary!
I’m afraid that no vaccine nor drug currently out there is going to work well because of the extensive mutation of the virus that has occurred so far.
A fellow I know is completely convinced that this means the end of the world. He’s established a redoubt in Santa Fe where he can be totally self-sufficient for up to a year. He asked me how long this could last. I have no idea but the mathematical models aren’t encouraging.
Senator Harkin is holding a hearing on the issue tomorrow in Washington.
Besides vaccines and drugs, there needs to be extremely accurate data collection so that predictions can be made as to the area of further spread. In that manner, preventative interventions can take place. That assumes, of course, an ideal world but unfortunately, the state of healthcare in the impacted countries leaves much to be desired.
Remember that plague swept throughout Europe in waves killing almost one third of the population in total….and it started small!
Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
eugene@nanoviricides.com
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange
On Sep 15, 2014, at 12:02 PM, I wrote:
It was posted this AM - no problem!
BTW, break a leg in Aspen and I don't mean skiing!
Me
On Mon, Sep 15, 2014 at 11:10 AM, <eugeneseymourmd@mac.com> wrote:
Now this one is scary!
http://www.wired.com/2014/09/r0-ebola/?mbid=social_fb
forgive me if I’ve sent this before
http://www.nytimes.com/2014/09/13/world/africa/us-scientists-see-long-fight-against-ebola.html?_r=1
Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
eugene@nanoviricides.com
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM